BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 18, Issue 3
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis
Copyright: ©Author(s) 2026.
World J Cardiol. Mar 26, 2026; 18(3): 116789
Published online Mar 26, 2026. doi: 10.4330/wjc.v18.i3.116789
Figure 6
Full Size Figure Download Figure
Figure 6 Forest plot for left ventricular ejection fraction following percutaneous coronary intervention in ST-segment elevation myocardial infarction patients receiving nicorandil after 1 week, 1 month, 3 months, and 6 months. A: Left ventricular ejection fraction (LVEF) at 1 week; B: LVEF at 1 month; C: LVEF at 3 months; D: LVEF at 6 months. Nicorandil was associated with significant improvement in LVEF at all follow-up intervals. No statistically significant differences were observed between subgroups stratified by route of administration at any follow-up interval. CI: Confidence interval; IV: Intravenous; IC: Intracoronary.
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.